Prophylactic mastectomy in patients at high risk: Is there a role for sentinel lymph node biopsy?

Clinical Breast Cancer

Volumn 13, Issue 3, 2013, Pages 180-187

  Murthy, Vijayashree ^a   Chamberlain, Ronald S ^a,b,c  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

^c ST GEORGE S UNIVERSITY   (Grenada)

Author keywords

Contralateral axillary metastases; Contralateral mastectomy; Prophylactic mastectomy; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CARCINOMA; CANCER SIZE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; OCCULT CANCER; PROPHYLAXIS; SENTINEL LYMPH NODE BIOPSY;

EID: 84876735233     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.12.001     Document Type: Article

References (37)

1. National Cancer Institute Preventive Mastectomy http://www.cancer.gov/ cancertopics/factsheet/Therapy/preventive-mastectomy Reviewed 7/27/2006. Accessed November 7, 2011
2. L.C. Hartmann, D.J. Schaid, J.E. Woods Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N Engl J Med 340 1999 77 84
3. L.C. Hartmann, T.A. Sellers, D.J. Schaid Efficacy of bilateral prophylactic mastectomy in BRCA 1 and BRCA 2 gene mutation carriers J Natl Cancer Inst 93 2001 1633 1637
4. T.R. Rebbeck, T. Friebel, H.T. Lynch Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol 22 2004 1055 1062
5. M.J. Lopez, K.A. Porter The current role of prophylactic mastectomy Surg Clin North Am 76 1996 231 242
6. T.M. Tuttle, E.B. Habermann, E.H. Grund Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment J Clin Oncol 25 2007 5203 5209
7. T.M. Tuttle, S. Jarosek, E.B. Habermann Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ J Clin Oncol 27 2009 1362 1367
8. S.K. McDonnell, D.J. Schaid, J.L. Myers Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer J Clin Oncol 19 2001 3938 3943
9. L.J. Herrinton, W.E. Barlow, O. Yu Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project J Clin Oncol 23 2005 4275 4286
10. I. Bedrosian, C.Y. Hu, G.J. Chang Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients J Natl Cancer Inst 102 2010 401 409
11. A.E. Giuliano, S. Boolbol, A. Degnim Society of Surgical Oncology: position statement on prophylactic mastectomy Approved by the Society of Surgical Oncology Executive Council, March 2007 Ann Surg Oncol 14 2007 2425 2427
12. G.M. Clark Prognostic and predictive factors J.R. Harris, M.E. Lippman, M. Morrow, Diseases of the Breast 2nd edition 2000 Lippincott Williams & Wilkins Philadelphia, PA 489 514
13. G.H. Lyman, A.E. Giuliano, M.R. Somerfield American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 2005 7703 7720
14. P.C. Sappey Anatomie, physiologie, pathologie des vaisseaux lymphatiques consideré chez L'Homme et les vertebras 1885 Lecosnier Paris, France
15. C.E. Cox, S. Pendas, J.M. Cox Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg 227 1998 645 651
16. K. Goldflam, K.K. Hunt, J.E. Gershenwald Contralateral prophylactic mastectomy Predictors of significant histologic findings Cancer 101 2004 1977 1986
17. T.A. King, I. Gurevich, R. Sakr Occult malignancy in patients undergoing prophylactic mastectomy Ann Surg 254 2011 2 7
18. K.K. Khurana, A. Loosmann, P.J. Numann Prophylactic mastectomy: pathologic findings in high-risk patients Arch Pathol Lab Med 124 2000 378 381
19. M. Yi, F. Meric-Bernstam, L.P. Middleton Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy Cancer 115 2009 962 971
20. C. Laronga, M.C. Lee, K.P. Mcguire Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy J Am Coll Surg 209 2009 746 752
21. E.L. Dupont, M.A. Kuhn, C. McCann The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy Am J Surg 180 2000 274 277
22. P. Schrenk, S. Wölfl, S. Bogner Symmetrization reduction mammaplasty combined with sentinel lymph node biopsy in patients operated for contralateral breast cancer J Surg Oncol 94 2006 9 15
23. D. Black, M. Specht, J.M. Lee Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy Ann Surg Oncol 14 2007 2477 2484
24. A. Soran, J. Falk, M. Bonaventura Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Women's Hospital experience Ann Surg Oncol 14 2007 646 651
25. S.A. McLaughlin, M. Stempel, E.A. Morris Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy? Cancer 112 2008 1214 1221
26. J.C. Boughey, T.L. Hoskin, A.C. Degnim Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer Ann Surg Oncol 17 2010 2702 2709
27. J.E. Devitt, A.W. Michalchuk Significance of contralateral axillary metastases in carcinoma of the breast Can J Surg 12 1969 178 180
28. J. Daoud, M. Meziou, M. Kharrat Contralateral axillary lymph node metastasis of cancer of the breast Bull Cancer 85 1998 713 715
29. J.C. Boughey, N. Khakpour, F. Meric-Bernstam Selective use of sentinel lymph node surgery during prophylactic mastectomy Cancer 107 2006 1440 1447
30. American Society of Breast Surgeons Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer, 2010 https://www.breastsurgeons.org/statements/2010-Nov-05-Guidelines-on-Performing- SLN.pdf Accessed: January 15, 2013.
31. A. Agarwal, D.E. Heron, J. Sumkin Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer J Surg Oncol 92 2005 4 8
32. N. Klauber-DeMore, L.K. Tan, L. Liberman Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7 2000 636 642
33. A.E. Giuliano, K.K. Hunt, K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis A randomized clinical trial JAMA 305 2011 569 575
34. T.A. King, J.V. Fey, K.J. Van Zee A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer Ann Surg Oncol 11 2004 535 541
35. P. Schrenk, R. Rieger, A. Shamiyeh Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer 88 2000 608 614
36. L.G. Wilke, L.M. McCall, K.E. Posther Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial Ann Surg Oncol 13 2006 491 500
37. R.E. Mansel, L. Fallowfield, M. Kissin Randomized multicenter trial of sentinel node biopsy versus axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 2006 599 609